ecancer

Non invasive biomarkers for prostate cancer

Dr David Ulmert - Memorial Sloan-Kettering Cancer Center, New York, USA; Dr Michael Evans - Memorial Sloan-Kettering Cancer Center, New York, USA

17 Apr 2012

Metformin to slow prostate cancer growth

Dr Anthony Joshua - Princess Margaret Hospital, Toronto, Canada

13 Apr 2012

Hypoxia influenced tumour behaviour in prostate cancer

Dr Michael Milosevic - University of Toronto, Ontario, Canada

13 Apr 2012

Biomarker identified in relation to pazopanib in refractory urothelial cancer

Dr Andrea Necchi - National Cancer Institute of Milan, Italy

$Biomarker identified in relation to pazopanib in refractory urothelial cancer ( Dr Andrea Necchi - National Cancer Institute of Milan, Italy )$

13 Apr 2012

Noninvasive imaging markers in prostate cancer

Dr Michael Evans - Memorial Sloan-Kettering Cancer Center, New York, USA

13 Apr 2012

Effects of vitamin D on prostate cancer

Prof Reinhold Vieth - University of Toronto, Ontario, Canada

13 Apr 2012

The latest in prostate cancer imaging

Prof Anwar Padhani - Mount Vernon Cancer Institute, UK

3 Feb 2012

Factors influencing prostate cancer in black men

Dr Folakemi Odedina - University of Florida, Gainseville, USA

14 Dec 2011

Ethnic variations in genetic basis of cancer

Dr Pedro Fernandez - Stellenbosch University, South Africa

12 Dec 2011

Disseminating information on prostate cancer in Africa

Virgil Simmons - TheProstateNet, Secaucus, NJ, USA

12 Dec 2011

Developing research programs in Africa

Dr Timothy Rebbeck - University of Pennsylvania, Philadelphia, USA

12 Dec 2011

Chemotherapy Foundation Symposium 2011

Prof Edward Ambinder - The Mount Sinai Hospital, New York, USA

24 Nov 2011

More from ecancer